New York S 2013: Makes provisions relating to the joint nomination of candidates for the offices of governor and lieutenant governor

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S02013 Summary:

BILL NOS02013 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORORTT

&nbsp

COSPNSROBERACKER

&nbsp

MLTSPNSR

&nbsp

Add §220.66, Pen L

&nbsp

Criminalizes the sale, use and possession of synthetic drugs; provides various definitions for types of synthetic drugs.

Go to top S02013 Actions:

BILL NOS02013 

&nbsp

01/14/2025REFERRED TO CODES

01/07/2026REFERRED TO CODES

Go to topS02013 Committee&nbspVotes:

Go to topS02013 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS02013 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 2013

 2025-2026 Regular Sessions

 IN SENATE

 January 14, 2025
 ___________

 Introduced by Sen. ORTT -- read twice and ordered printed, and when
 printed to be committed to the Committee on Codes

 AN ACT to amend the penal law, in relation to the criminalization of
 selling, using or possessing synthetic drugs

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The penal law is amended by adding a new section 220.66 to
 2 read as follows:
 3 § 220.66 Criminal sale, use or possession of synthetic drugs and other
 4 similar compounds.
 5 A person is guilty of the criminal sale, use or possession of synthet-
 6 ic drugs and other similar compounds when they knowingly and unlawfully
 7 sell, use and/or possess any synthetic drug, unless such synthetic drug
 8 has been expressly prescribed to such person by a physician, psychia-
 9 trist or person otherwise duly licensed and authorized to prescribe
 10 medication within New York state, and at the time of the alleged
 11 violation, the person in possession of the synthetic drug is able to
 12 provide written proof to the law enforcement officer that the synthetic
 13 drug was so prescribed. Each such violation shall constitute a separate
 14 and distinct offense. For purposes of this section:
 15 1. "synthetic drug" shall mean any product, whether described as
 16 tobacco, potpourri, herbs, incense, spice, aromatic, bath salts,
 17 synthetic marijuana, synthetic stimulant or any combination thereof, and
 18 whether marketed for the purpose of being ingested otherwise marketed
 19 which includes, but is not limited to, one or more of the following
 20 hallucinogenic substances:
 21 (a) "synthetic cannabinoids" shall mean any substance that is a canna-
 22 binoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding
 23 studies and function assays or is a structural analog or chemical deriv-
 24 ative of any listed compound, as follows:

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD00775-01-5

 S. 2013 2

 1 (i) 2-[(1R, 2R, 5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohex-
 2 yl]-5-(2-methyloctan-2-yl)phenol
 3 (ii) 4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]
 4 methanone
 5 (iii) [(3R)-5-Methyl-3-(morpholin-4-ylmethyl)-2,
 6 3-dihydro[1,4}oxazino[2,3,4-hi]indol-6-yl](naphthalene-1-yl)methanone
 7 (iv) (2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone
 8 (v) (2-Methyl-1-propyl-1H-indol-3-yl)(naphthalene-1-yl)methanone
 9 (vi) Naphthalen-1-yl[1-(pen-4-en-1-yl)-1H-indol-3-yl)methanone
 10 (vii) 1-pentyl-3-(4-ethyl-1-naphthoyl)indole
 11 (viii) 1-pentylindol-3-yl)napthalen-1-ylmethane
 12 (ix) (1-Pentyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone
 13 (x) 3-[(4-methyl-1-naphthaleny)methyl]-1-pentyl-1H-indole
 14 (xi) 1-([(1E)-3-pentylinden-1-ylidine]methyl)naphthalene
 15 (xii) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-e-yl)ethanone
 16 (xiii) 2-(3-methoxylphenyl)-1-(1-pentylindol-3-yl)ethanone
 17 (xiv) (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone
 18 (xv) 1-pentyl-3-(2-iodobenzoyl)indole
 19 (xvi) [1-[(1-Methyl-2-piperidinyl)methyl]-3-indolyl]-(1-naphthalenyl)
 20 methanone
 21 (xvii) 1-[(N-methylpiperidin-2-yl)methyl]3-(adaman-1-oyl)indole
 22 (xviii) (2-lodophenyl){1-[1-methylpiperidin-2-yl)methyl]-1H-indole-3-yl}
 23 methanone
 24 (xix) (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
 25 (xx) [1-(5-Fluoropentyl)-1H-indol-3-yl])2,2,3,3-tetramethylcyclopropyl)
 26 methanone
 27 Unless specifically exempted or unless listed in another schedule, or
 28 approved for use by the Food and Dru